Stock listing
NASDAQ:BDMD Baird Medical Investment Holdings Ltd Stock
Home listing (NASDAQ) of Baird Medical Investment Holdings Ltd
Follow Baird Medical Investment Holdings Ltd into a list and get an email when it puts out news.
Share price · NASDAQ:BDMD
$0.09 USD +0.01 (+13.4%)
Close on Nov 20, 2026
- Day range
- $0.086 – $0.099 USDNov 20, 2026
- Volume
- 1.60M sharesNov 20, 2026
- Market cap
- $2.88M USDAt the close on Nov 20, 2026 · price × 32.11M shares outstanding
- 52-week range
- $0.073 – $3.70 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $2.10M USDMedian day 57,700 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BDMD · Home | $0.09 USD | +0.011 (+13.4%) | 1,599,322 | $0.095 | $0.099 | $0.086 | $0.079 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:BDMD · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.09 | +0.011 | +13.4% | $0.095 | $0.099 | $0.086 | 1,599,322 | |
| $0.079 | -0.013 | -13.8% | $0.094 | $0.094 | $0.075 | 6,324,796 | |
| $0.092 | -0.015 | -13.8% | $0.092 | $0.094 | $0.089 | 4,213,292 | |
| $0.107 | +0.016 | +17.7% | $0.088 | $0.116 | $0.084 | 20,848,262 | |
| $0.091 | -0.017 | -15.7% | $0.097 | $0.099 | $0.08 | 11,488,365 | |
| $0.107 | +0.003 | +3.2% | $0.104 | $0.109 | $0.091 | 100,259,464 | |
| $0.104 | +0.007 | +7.2% | $0.112 | $0.159 | $0.094 | 151,164,832 | |
| $0.097 | -0.015 | -13.7% | $0.098 | $0.102 | $0.09 | 17,103,341 | |
| $0.112 | +0.024 | +27.7% | $0.09 | $0.115 | $0.088 | 87,127,233 | |
| $0.088 | -0.07 | -44.3% | $0.107 | $0.115 | $0.082 | 34,194,400 | |
| $0.158 | +0.049 | +45.0% | $0.102 | $0.195 | $0.10 | 380,619,600 | |
| $0.109 | -0.008 | -6.8% | $0.095 | $0.115 | $0.095 | 5,845,500 | |
| $0.117 | -0.021 | -15.2% | $0.105 | $0.137 | $0.093 | 24,835,500 | |
| $0.138 | -0.022 | -13.7% | $0.196 | $0.196 | $0.073 | 169,242,900 | |
| $0.16 | -0.028 | -14.9% | $0.18 | $0.27 | $0.133 | 9,661,700 | |
| $0.188 | -0.062 | -24.8% | $0.25 | $0.253 | $0.162 | 901,700 | |
| $0.25 | -0.032 | -11.3% | $0.246 | $0.29 | $0.23 | 392,500 | |
| $0.282 | -0.146 | -34.1% | $0.342 | $0.456 | $0.225 | 1,523,600 | |
| $0.428 | -0.018 | -4.0% | $0.446 | $0.474 | $0.411 | 58,400 | |
| $0.446 | -0.007 | -1.5% | $0.45 | $0.475 | $0.445 | 59,600 | |
| $0.453 | -0.023 | -4.8% | $0.471 | $0.491 | $0.453 | 35,600 | |
| $0.476 | -0.006 | -1.2% | $0.462 | $0.549 | $0.462 | 31,300 | |
| $0.482 | +0.046 | +10.6% | $0.436 | $0.486 | $0.436 | 57,700 | |
| $0.436 | -0.13 | -23.0% | $0.569 | $0.60 | $0.40 | 186,500 | |
| $0.566 | -0.034 | -5.7% | $0.60 | $0.641 | $0.55 | 53,900 | |
| $0.60 | +0.049 | +8.9% | $0.552 | $0.619 | $0.55 | 80,000 | |
| $0.551 | -0.134 | -19.6% | $0.685 | $0.714 | $0.511 | 127,200 | |
| $0.685 | -0.065 | -8.7% | $0.678 | $0.731 | $0.678 | 43,800 | |
| $0.75 | -0.02 | -2.6% | $0.74 | $0.80 | $0.66 | 67,200 | |
| $0.77 | -0.02 | -2.5% | $0.766 | $0.808 | $0.76 | 50,100 | |
| $0.79 | 0.00 | 0.0% | $0.77 | $0.83 | $0.77 | 67,000 | |
| $0.79 | +0.01 | +1.3% | $0.74 | $0.812 | $0.74 | 64,500 | |
| $0.78 | +0.037 | +5.0% | $0.73 | $0.802 | $0.73 | 41,400 | |
| $0.743 | -0.008 | -1.1% | $0.746 | $0.85 | $0.74 | 51,900 | |
| $0.751 | +0.007 | +0.9% | $0.73 | $0.81 | $0.73 | 48,900 | |
| $0.744 | -0.036 | -4.6% | $0.77 | $0.821 | $0.744 | 57,000 | |
| $0.78 | -0.018 | -2.3% | $0.76 | $0.799 | $0.73 | 57,800 | |
| $0.798 | +0.025 | +3.2% | $0.735 | $0.845 | $0.73 | 18,200 | |
| $0.773 | +0.006 | +0.8% | $0.735 | $0.877 | $0.735 | 46,100 | |
| $0.767 | -0.013 | -1.7% | $0.761 | $0.82 | $0.73 | 50,000 | |
| $0.78 | -0.01 | -1.3% | $0.79 | $0.80 | $0.751 | 25,400 | |
| $0.79 | 0.00 | 0.0% | $0.769 | $0.82 | $0.732 | 187,900 | |
| $0.79 | -0.051 | -6.1% | $0.831 | $0.92 | $0.661 | 226,100 | |
| $0.841 | -0.209 | -19.9% | $1.02 | $1.04 | $0.744 | 203,900 | |
| $1.05 | +0.01 | +1.0% | $1.03 | $1.09 | $1.02 | 25,300 | |
| $1.04 | -0.02 | -1.9% | $1.08 | $1.13 | $1.037 | 33,900 | |
| $1.06 | 0.00 | 0.0% | $1.07 | $1.12 | $1.04 | 51,900 | |
| $1.06 | 0.00 | 0.0% | $1.06 | $1.09 | $1.03 | 40,900 | |
| $1.06 | -0.04 | -3.6% | $1.11 | $1.149 | $1.06 | 48,300 | |
| $1.10 | +0.02 | +1.9% | $1.08 | $1.14 | $1.08 | 43,900 | |
| $1.08 | -0.04 | -3.6% | $1.10 | $1.12 | $1.05 | 19,800 | |
| $1.12 | +0.02 | +1.8% | $1.11 | $1.15 | $1.06 | 58,500 | |
| $1.10 | +0.01 | +0.9% | $1.08 | $1.157 | $1.05 | 43,300 | |
| $1.09 | -0.08 | -6.8% | $1.16 | $1.19 | $1.08 | 34,500 | |
| $1.17 | +0.05 | +4.5% | $1.15 | $1.20 | $1.10 | 49,600 | |
| $1.12 | -0.02 | -1.8% | $1.11 | $1.14 | $1.08 | 14,800 | |
| $1.14 | +0.04 | +3.6% | $1.07 | $1.17 | $1.058 | 33,500 | |
| $1.10 | -0.02 | -1.8% | $1.10 | $1.17 | $1.06 | 39,000 | |
| $1.12 | +0.01 | +0.9% | $1.12 | $1.163 | $1.08 | 24,400 | |
| $1.11 | -0.07 | -5.9% | $1.14 | $1.21 | $1.11 | 31,400 | |
| $1.18 | -0.02 | -1.7% | $1.20 | $1.24 | $1.15 | 35,400 | |
| $1.20 | +0.04 | +3.4% | $1.16 | $1.25 | $1.15 | 20,800 | |
| $1.16 | 0.00 | 0.0% | $1.14 | $1.25 | $1.14 | 19,600 | |
| $1.16 | 0.00 | 0.0% | $1.16 | $1.24 | $1.14 | 26,300 | |
| $1.16 | -0.03 | -2.5% | $1.10 | $1.24 | $1.10 | 78,700 |
- Ticker
- NASDAQ:BDMD
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 12, 2026
Baird Medical Enters South Korea Market through Strategic Distribution Partnership with ALLIS MED
Latest news
Baird Medical Enters South Korea Market through Strategic Distribution Partnership with ALLIS MED
Nov 12, 2026
Closed $0.107 (+3.2%) on Nov 12, 2026
Baird Medical and Alpmed Announce FDA 510(k) and EU CE Submissions for Irreversible Electroporation (IRE) System
Nov 5, 2026
Closed $0.158 (+45.0%) on Nov 5, 2026
Baird Medical Issues Statement Regarding Recent Share Price Volatility
Nov 4, 2026
Closed $0.158 (+45.0%) on Nov 5, 2026
Baird Medical Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Nov 4, 2026
Closed $0.158 (+45.0%) on Nov 5, 2026
Baird Medical and China Resources Pharmaceutical Commercial Group Medical Devices Sign Strategic Distribution Agreement to Expand Access to Microwave Ablation in China
Nov 2, 2026
Closed $0.138 (-13.7%) on Nov 2, 2026
Baird Medical Announces Regulatory Milestones in Vietnam and Egypt, Expanding International Reach of Microwave Ablation Technology
Oct 19, 2026
Closed $0.436 (-23.0%) on Oct 19, 2026
Baird Medical Highlights Global Expansion and Strategic Progress During Third Quarter 2026
Oct 5, 2026
Closed $0.743 (-1.1%) on Oct 5, 2026
Baird Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 15, 2026
Closed $1.06 (0.0%) on Sep 15, 2026
Baird Medical Highlights Participation at CIRSE 2026 and Showcases Microwave Ablation Technology
Sep 14, 2026
Closed $1.06 (-3.6%) on Sep 14, 2026
Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026
Sep 3, 2026
Closed $1.17 (+4.5%) on Sep 3, 2026
Baird Medical Investment Holdings Ltd on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 31 in the last 12 months · 63 in all · newest Nov 12, 2026 · oldest 2024
- Decks
- 4 decks · latest Jun 27, 2024
Where Baird Medical Investment Holdings Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BDMD · Home listing · This page | NASDAQ | United States | USD |
| BOATS:BDMD | BOATS | United States | USD |
Valuation
EV/sales 0.8× against a median of 0.3×: 8th lowest of 10 Medical devices & supplies companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $16.81M USD
- P/E
- Loss
- EV/sales
- 0.8×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.1×
- Gross margin
- 83.8%
- Operating margin
- −113.7%
- Net margin
- −121.0%
- Debt to equity
- 0.4×
- Beta vs S&P 500
- -0.13
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Baird Medical Investment Holdings Ltd · NASDAQ:BDMD | US$2.88M | US$16.81M | n/a | 0.8× | n/a | 0.1× | −121.0% | 0.4× | -0.13 |
| IceCure Medical Ltd. · NASDAQ:ICCM | US$3.71M | −US$3.80M | n/a | −1.0× | n/a | 0.4× | −439.7% | 0.1× | 1.98 |
| enVVeno Medical Corporation · NASDAQ:NVNO | US$3.65M | −US$14.82M | n/a | n/a | n/a | 0.2× | n/a | 0.0× | 1.12 |
| Spineway SA · EURONEXT:ALSPW | US$3.63M | US$1.46M | n/a | 0.1× | n/a | 0.1× | −18.0% | 0.1× | n/a |
| ScandiDos AB · OMXSTO:SDOS | US$2.84M | US$1.51M | n/a | 0.3× | n/a | 0.6× | −16.4% | 0.1× | n/a |
| Beyond Air, Inc. · NASDAQ:XAIR | US$2.57M | −US$8.48M | n/a | −1.0× | n/a | 0.5× | −407.3% | 0.0× | 1.13 |
| Tenon Medical, Inc. · NASDAQ:TNON | US$2.41M | −US$4.57M | n/a | −0.8× | n/a | 0.3× | −305.1% | 0.1× | 1.79 |
| NuGen Medical Devices Inc · TSXV:NGMD | US$2.37M | US$12.62M | n/a | 122× | n/a | n/a | n/a | n/a | 0.35 |
| LKL International Bhd. · MYX:LKL | US$2.36M | US$4.15M | n/a | 0.3× | n/a | 0.1× | −46.9% | 0.2× | n/a |
| RemSleep Holdings, Inc. · OTC:RMSL | US$2.09M | US$2.06M | n/a | 123× | n/a | n/a | n/a | n/a | -0.01 |
| Fuse Medical, Inc. · OTC:FZMD | US$2.03M | US$4.31M | 14.8× | 0.5× | 7.8× | 0.3× | 1.5% | 0.4× | 0.54 |
| Median of the others | US$2.49M | US$1.49M | 14.8× | 0.3× | 7.8× | 0.3× | −46.9% | 0.1× | 1.12 |
Forecasts
Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.
- Price target
- 4.00 USD · Analysts' mean
- EPS, year to Dec 2026
- 0.080 · 1 analyst
- Revenue, year to Dec 2026
- 27.52M · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Haimei Wu | Chairwoman of the Board and Chief Executive Officer |
| Quan Qiu | Executive Director and Chief Administrative Officer |
| Wei Hou | Executive Director |
Board
| Director | Role |
|---|---|
| Haimei Wu | Chairwoman of the Board and Chief Executive Officer |
| Gabrielle Wolfson | Independent Director |
| Joseph Douglas Ragan | Director |
| Lijian Xu | Independent Director |
| Mingzhao Xing | Independent Director |
| Quan Qiu | Executive Director and Chief Administrative Officer |
| Wei Hou | Executive Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2025 | Dec 5, 2025 | −4.9% |
| Q1 2025 | May 15, 2025 | −1.0% |
| Q3 2024 | Nov 15, 2024 | −3.2% |
| Quarter to Dec 31, 2022 | Mar 30, 2023 | |
| Quarter to Sep 30, 2022 | Nov 14, 2022 | |
| Quarter to Jun 30, 2022 | Aug 15, 2022 | |
| Quarter to Mar 31, 2022 | May 13, 2022 | |
| Quarter to Dec 31, 2021 | Mar 31, 2022 | |
| Quarter to Sep 30, 2021 | Oct 5, 2021 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| SPAC Merger (June 2024) | SPAC merger | 32 slides | Jun 27, 2024 |
| SPAC Merger (March 2024) | SPAC merger | 32 slides | Mar 18, 2024 |
| SPAC Merger (January 2024) | SPAC merger | 33 slides | Jan 26, 2024 |
| SPAC Merger (December 2023) | SPAC merger | 33 slides | Dec 12, 2023 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 22.5M | 37.0M | 31.5M | 35.1M | 27.7M | 18.1M | 12.2M |
| Cost of revenue | 3.65M | 4.38M | 4.23M | 7.05M | 4.54M | 2.51M | 1.30M |
| Gross profit | 18.9M | 32.7M | 27.2M | 28.0M | 23.2M | 15.6M | 10.9M |
| Research and development | 20.1M | 6.17M | 4.27M | 3.86M | 1.04M | 750.5K | 1.16M |
| Selling, general and administrative | 14.1M | 5.90M | 8.55M | 6.96M | 6.65M | 2.16M | 1.10M |
| Operating income | -25.6M | 15.3M | 11.9M | 13.6M | 11.9M | 9.86M | 5.61M |
| Depreciation and amortization | 1.10M | 1.14M | 1.01M | 916.1K | 1.40M | 1.07M | 638.1K |
| EBITDA | -24.5M | 16.5M | 12.9M | 14.5M | 13.3M | 10.9M | 6.25M |
| Interest expense | 737.4K | 576.4K | 284.3K | 299.3K | 153.9K | 159.5K | 89.6K |
| Income before tax | -26.4M | 14.1M | 12.4M | 14.5M | 12.6M | 9.58M | -5.85M |
| Income tax | 1.17M | 1.49M | 1.70M | 1.75M | 2.42M | 2.43M | 1.28M |
| Net income | -27.3M | 12.5M | 10.5M | 12.6M | 11.7M | 7.10M | -7.18M |
| Earnings per share, basic | -0.98 | 0.57 | 0.51 | 0.49 | 1.62 | 0.99 | -1.00 |
| Earnings per share, diluted | -0.98 | 0.57 | 0.51 | 0.49 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 178.3K | 2.97M | 1.51M | 1.71M | 3.03M | 1.07M | 220.5K |
| Short-term investments | 295.8K | 120.5K | 197.0K | 407.5K | 65.1K | 36.6K | |
| Receivables | 42.5M | 46.6M | 31.1M | 24.8M | 12.4M | 8.23M | 4.56M |
| Inventory | 1.09M | 1.30M | 1.14M | 1.29M | 3.06M | 810.1K | 709.5K |
| Current assets | 55.0M | 61.4M | 40.1M | 33.8M | 22.4M | 13.1M | 8.67M |
| Property, plant and equipment | 6.37M | 7.14M | 6.14M | ||||
| Goodwill | 60.3K | 57.8K | 59.4K | 61.1K | 66.2K | 64.6K | 60.6K |
| Total assets | 69.7M | 78.0M | 56.7M | 42.6M | 26.1M | 17.0M | 11.8M |
| Accounts payable | 1.81M | 1.25M | 550.2K | 215.9K | 340.2K | 61.1K | 100.2K |
| Current liabilities | 32.4M | 34.6M | 19.0M | 16.0M | 9.77M | 9.25M | 33.6M |
| Long-term debt | 6.09M | 3.44M | 1.61M | ||||
| Total debt | 8.72M | 4.45M | 2.43M | 7.44M | 2.93M | 4.05M | 28.9M |
| Total liabilities | 38.5M | 38.2M | 21.0M | 16.8M | 10.3M | 10.3M | 34.3M |
| Shareholders' equity | 31.4M | 39.7M | 35.8M | 25.8M | 5.20M | 7.21M | -21.9M |
| Shares outstanding | 30.8M | 25.6M | 29.4M | 41.0M | 7.19M | 7.19M | 7.19M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -1.34M | -6.31M | -1.02M | 486.0K | 5.26M | 3.91M | 4.41M |
| Capital spending | -42.3K | -2.85M | -2.64M | -5.91M | -1.39M | -655.4K | -983.8K |
| Free cash flow | -1.39M | -9.17M | -3.66M | -5.42M | 3.87M | 3.25M | 3.43M |
| Cash from investing | -42.3K | -2.47M | -2.65M | -5.92M | -1.39M | -2.17M | 1.18M |
| Cash from financing | -1.39M | 10.3M | 3.48M | 4.41M | -1.93M | -899.1K | -5.72M |
| Dividends paid | 0 | -5.43M | |||||
| Change in cash | -2.40M | 1.46M | -200.4K | -1.32M | 1.96M | 850.8K | 220.5K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 6-K · Report of a foreign issuer | Nov 16, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Nov 5, 2026 | Current report | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 1, 2026 | Big-stake notice | SEC |
| 6-K · Report of a foreign issuer | Sep 30, 2026 | Current report | SEC |
| 6-K · Report of a foreign issuer | Sep 30, 2026 | Current report | SEC |
| 424B5 · Prospectus | Sep 24, 2026 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Sep 3, 2026 | Current report | SEC |
| 424B3 · Prospectus | Aug 18, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Aug 18, 2026 | Other filings | SEC |
| EFFECT · Notice that a registration is effective | Aug 18, 2026 | Other filings | SEC |
All 90 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| POS AM · Amendment to an effective registration | Aug 6, 2026 | Offer document | SEC |
| F-3/A · Registration statement, amended | Aug 6, 2026 | Offer document | SEC |
| 3 · Initial statement of ownership | Jul 31, 2026 | Insider trade | SEC |
| SCHEDULE 13D · Big-stake notice | Jul 31, 2026 | Big-stake notice | SEC |
| 20-F/A · Annual report, amended | Jul 27, 2026 | Annual report | SEC |
| POS AM · Amendment to an effective registration | May 22, 2026 | Offer document | SEC |
| F-3 · Registration statement | May 22, 2026 | Offer document | SEC |
| SCHEDULE 13G · Big-stake notice | May 8, 2026 | Big-stake notice | SEC |
| 20-F · Annual report | Apr 24, 2026 | Annual report | SEC |
| 3 · Initial statement of ownership | Apr 21, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 21, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 21, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 17, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 15, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 31, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 31, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 27, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Mar 10, 2026 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Feb 10, 2026 | Current report | SEC |
| 424B3 · Prospectus | Jan 16, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jan 16, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 13, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Dec 5, 2025 | Other filings | SEC |
| F-1/A · Registration statement, amended | Dec 5, 2025 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Dec 5, 2025 | Current report | SEC |
| UPLOAD · Letter from the SEC | Aug 20, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Aug 8, 2025 | Other filings | SEC |
| F-1/A · Registration statement, amended | Aug 8, 2025 | Offer document | SEC |
| 20-F · Annual report | May 15, 2025 | Annual report | SEC |
| NT 20-F | Apr 30, 2025 | Explanation request | SEC |
| UPLOAD · Letter from the SEC | Feb 3, 2025 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Jan 28, 2025 | Current report | SEC |
| CORRESP · Letter to the SEC | Jan 17, 2025 | Other filings | SEC |
| F-1/A · Registration statement, amended | Jan 17, 2025 | Offer document | SEC |
| S-8 · Registration statement for employee plans | Jan 10, 2025 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Dec 6, 2024 | Other filings | SEC |
| F-1 · Registration statement | Nov 15, 2024 | Offer document | SEC |
| 6-K · Report of a foreign issuer | Nov 1, 2024 | Current report | SEC |
| 20FR12B | Oct 9, 2024 | Other filings | SEC |
| CERT · Exchange's certificate of listing | Oct 2, 2024 | Other filings | SEC |
| 6-K · Report of a foreign issuer | Oct 1, 2024 | Current report | SEC |
| 8-A12B · Registration of shares for listing on an exchange | Oct 1, 2024 | Other filings | SEC |
| EFFECT · Notice that a registration is effective | Sep 6, 2024 | Other filings | SEC |
| 425 | Sep 5, 2024 | Other filings | SEC |
| SEC STAFF LETTER | Sep 5, 2024 | Other filings | SEC |
| 424B3 · Prospectus | Sep 5, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Sep 3, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Aug 26, 2024 | Other filings | SEC |
| F-4/A | Aug 26, 2024 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Aug 22, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Aug 9, 2024 | Other filings | SEC |
| F-4/A | Aug 9, 2024 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Aug 1, 2024 | Other filings | SEC |
| SEC STAFF LETTER | Jul 30, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 19, 2024 | Other filings | SEC |
| F-4/A | Jul 19, 2024 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Jul 8, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 20, 2024 | Other filings | SEC |
| F-4/A | Jun 20, 2024 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Apr 2, 2024 | Other filings | SEC |
| 425 | Mar 18, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Mar 15, 2024 | Other filings | SEC |
| F-4/A | Mar 15, 2024 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Feb 6, 2024 | Other filings | SEC |
| 425 | Jan 26, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 19, 2024 | Other filings | SEC |
| F-4/A | Jan 19, 2024 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Dec 20, 2023 | Other filings | SEC |
| 425 | Dec 12, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Nov 28, 2023 | Other filings | SEC |
| F-4/A | Nov 28, 2023 | Offer document | SEC |
| 425 | Nov 22, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Sep 20, 2023 | Other filings | SEC |
| F-4 | Aug 21, 2023 | Offer document | SEC |
| 425 | Aug 1, 2023 | Other filings | SEC |
| 425 | Aug 1, 2023 | Other filings | SEC |
| 425 | Jun 26, 2023 | Other filings | SEC |
| 425 | Jun 26, 2023 | Other filings | SEC |
| 425 | Jun 26, 2023 | Other filings | SEC |
| 425 | Jun 26, 2023 | Other filings | SEC |
Cap table
Built by 6ix from Baird Medical Investment Holdings Ltd’s releases
- Common shares
- 32,112,440
- Fully diluted
- 32,112,440
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 32,112,440 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 32,112,440 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Joseph Douglas Ragan III Other companies: ExcelFin Acquisition Corp (Chief Financial Officer · Oct 20, 2021 – Oct 20, 2021 · Past); Resideo Technologies, Inc. (EVP & Chief Financial Officer · Oct 3, 2018 – Jun 5, 2019 · Past) | Director · Since at least Mar 18, 2026 |
| Gabrielle Wolfson | Independent Director · Since at least Mar 18, 2026 |
| Haimei Wu | Chairwoman of the Board and Chief Executive Officer · Since at least Mar 27, 2026 |
| Jie Clara Li | Acting Chief Financial Officer · Since at least Apr 15, 2026 |
| Joseph Douglas Ragan | Director · Since at least Nov 5, 2026 |
| Lijian Xu | Independent Director · Since at least Apr 21, 2026 |
| Mark Saxton | CEO of Baird Medical's U · Dec 3, 2025 – Nov 5, 2026 · Past |
| Mingzhao Xing | Independent Director · Since at least Apr 14, 2025 |
| Quan Qiu | Executive Director and Chief Administrative Officer · Since at least Apr 21, 2026 |
| Rongjian Lu | Chief Technical Officer · Since at least Apr 21, 2026 |
All 11 people
| Person | Seat |
|---|---|
| Wei Hou | Executive Director · Since at least Mar 31, 2026 |
Log in to ask 6ix AI your own questions about Baird Medical Investment Holdings Ltd.